Evidence map›Paper›PMID 36138053›Full record

ArticleScientific reports2022

BCGΔBCG1419c increased memory CD8

Kee Woong Kwon, Michel de Jesús Aceves-Sánchez, Cristian Alfredo Segura-Cerda, Eunsol Choi, Helle Bielefeldt-Ohmann, Sung Jae Shin, Mario Alberto Flores-Valdez

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. CD8+ lymphocytes in immunity against tuberculosis.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  4. Article
  5. Vaccination with aMicroorganisms · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. The Induction of Antigen 85B-Specific CD8International journal of molecular sciences · 2023
    Article
  17. Delivery ofFrontiers in immunology · 2023
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Kee Woong KwonDepartment of Microbiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Michel de Jesús Aceves-SánchezBiotecnología Médica y Farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, A.C., Av. Normalistas No. 800, Col. Colinas de la Normal, 44270, Guadalajara, JAL, Mexico.
Cristian Alfredo Segura-CerdaBiotecnología Médica y Farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, A.C., Av. Normalistas No. 800, Col. Colinas de la Normal, 44270, Guadalajara, JAL, Mexico.
Eunsol ChoiDepartment of Microbiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Helle Bielefeldt-OhmannAustralian Infectious Diseases Research Centre, The University of Queensland, Saint Lucia, QLD, Australia.
Sung Jae ShinDepartment of Microbiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, South Korea. sjshin@yuhs.ac.
Mario Alberto Flores-ValdezBiotecnología Médica y Farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, A.C., Av. Normalistas No. 800, Col. Colinas de la Normal, 44270, Guadalajara, JAL, Mexico. floresv@ciatej.mx.
Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de JaliscoYonsei University · KRUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we reported that a hygromycin resistant version of the BCGΔBCG1419c vaccine candidate reduced tuberculosis (TB) disease in BALB/c, C57BL/6, and B6D2F1 mice infected with Mycobacterium tuberculosis (Mtb) H37Rv. Here, the second-generation version of BCGΔBCG1419c (based on BCG Pasteur ATCC 35734, without antibiotic resistance markers, and a complete deletion of BCG1419c) was compared to its parental BCG for immunogenicity and protective efficacy against the Mtb clinical isolate M2 in C57BL/6 mice. Both BCG and BCGΔBCG1419c induced production of IFN-γ, TNF-α, and/or IL-2 by effector memory (CD44

Indexed as

Mycobacterium tuberculosisPneumoniaTuberculosisAnimalsBCG VaccineCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesInterleukin-10Interleukin-2MiceMice, Inbred BALB CMice, Inbred C57BLTuberculinTumor Necrosis Factor-alphaBCG VaccineInterleukin-10Interleukin-2TuberculinTumor Necrosis Factor-alpha

Identifiers

PMID36138053
PMCPMC9499934
OpenAlexW4296690691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.